Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
BWXT Transcript
BWX Technologies, Inc. (BWXT) Q1 2026 Earnings Call Transcript
Unknown5-5
The earnings call summary presents a mixed picture. While there are positive elements such as strong growth in the Medical segment and unique positioning in TRISO fuel production, there are concerns about delivery risks in nuclear projects and high CapEx. The Q&A section highlights uncertainties, such as unclear timelines for key projects and potential delivery risks, which could weigh on investor sentiment. Without a clear market cap, it's challenging to gauge the exact impact, but the presence of both positive and negative factors suggests a neutral stock price movement.
BWX Technologies, Inc. (BWXT) Q4 2025 Earnings Call Transcript
Positive2-23
The earnings call highlighted strong financial performance with record revenue and significant growth in operating income, net income, and free cash flow. The strategic outlook for 2026 is optimistic, with expectations of continued growth in key segments like government and commercial operations. While there are risks associated with forward-looking statements and reliance on non-GAAP measures, the overall sentiment is positive. The absence of shareholder return plans does not significantly impact the positive outlook due to strong financial metrics and optimistic guidance.
BWX Technologies, Inc. (BWXT) Q3 2025 Earnings Call Transcript
Positive11-3
The earnings call summary and Q&A session indicate strong financial metrics with raised guidance across revenue, EBITDA, EPS, and free cash flow. The Kinectrics acquisition and government/commercial operations show promising growth. Despite some risks, such as lower initial margins and delayed Project Pele delivery, the market strategy with SMRs and medical segment growth is optimistic. The positive sentiment is further supported by the strategic partnerships and opportunities in nuclear energy. Overall, the outlook suggests a positive stock price movement, likely in the 2% to 8% range.
BWX Technologies, Inc. (BWXT) Q2 2025 Earnings Call Transcript
Positive8-4
The earnings call summary shows strong strategic developments, including backlog growth, new contracts, and expansion plans, indicating positive future prospects. The Q&A section reveals proactive measures addressing bottlenecks and strategic partnerships, with analysts showing interest in nuclear and microreactor markets. Despite some uncertainties, the guidance remains optimistic, with a focus on revenue growth and margin expectations. The overall sentiment leans towards positive, suggesting a stock price increase over the next two weeks.
BWXT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
